Melinta Therapeutics

Get Full Access

Description

  • Melinta Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to introducing new antibiotics that meet the ever-present challenge posed by dangerous and increasingly resistant bacteria. We are completing Phase 3 development of our late-stage investigational antibiotic, Baxdela (delafloxacin), for serious hospital-treated skin infections known as acute bacterial skin and skin structure infections (ABSSSI). Melinta is also developing, through the application of Nobel Prize-winning science and a proprietary drug discovery platform, novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter species and Escherichia coli), which cause the majority of life-threatening hospital infections.Melinta Therapeutics is privately held with offices in New Haven, CT and Lincolnshire, IL.
  • location

    Headquarters:300 Tri State Intl Ste 272 , Lincolnshire, Illinois, United States

    More
  • Melinta Therapeutics phone

    Phone Number: +1 203-624-5606

  • Melinta Therapeutics website

    Website: melinta.com

  • Melinta Therapeutics employees

    Employees:170

  • Melinta Therapeutics revenue

    Revenue:$100 - 250M

  • Melinta Therapeutics legal name

    Legal Name:Melinta Therapeutics

  • Melinta Therapeutics's Social Media

    Melinta Therapeutics linkedin Melinta Therapeutics twitter
  • done Is this data correct?
  • |  NAICS Code: 325412  |

    Show More
Person level website identification

Chief Financial Officer for Melinta Therapeutics

Peter Milligan

Chief Financial Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Peter Milligan

Chief Financial Officer

Kristen Allgor

Chief Human Resources Officer

John Harlow

Chief Commercial Officer

Susan Blum

Chief Financial Officer

Christine Miller

President And Member, Board Of Directors

Frequently Asked Questions regarding Melinta Therapeutics

  • Where are Melinta Therapeutics's Headquarters?

    Melinta Therapeutics's Headquarters are in 300 Tri State Intl Ste 272 ,Lincolnshire,Illinois,United States

  • What is Melinta Therapeutics's phone number?

    Melinta Therapeutics's phone number is +1 203-624-5606

  • What is Melinta Therapeutics's official website?

    Melinta Therapeutics's official website is melinta.com

  • What is Melinta Therapeutics's Revenue?

    Melinta Therapeutics's revenue is $100 - 250M

  • What is Melinta Therapeutics's NAICS code?

    Melinta Therapeutics's NAICS code is 325412

  • How many employees are working in Melinta Therapeutics

    Melinta Therapeutics has 170 employees

  • What is Melinta Therapeutics's Industry?

    Melinta Therapeutics is in the industry of Biotechnology

  • Who is Melinta Therapeutics's Chief Financial Officer?

    Melinta Therapeutics's Chief Financial Officer is Peter Milligan

Company Directory